Illustration of the effects of long-term xamoterol therapy on the time course of left ventricular pressure.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 1971598.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Detailed left ventricular haemodynamic investigations were performed in eight patients with New York Heart Association (NYHA) Class II heart failure, eight with NYHA Class III heart failure with an ejection fraction less than 35%, and six with severe heart failure. Xamoterol (200 mg b.d. for 3 months) caused a fall in left ventricular end-diastolic pressure, an increase in dP/dTmax and a shorter systole in all groups of patients.
Medical subject headings
- Adrenergic beta-Agonists
- Heart
- Myocardial Contraction
- Propanolamines